Blink Biomedical: Announces Close of Series A Funding LYON, France, July 12, 2016 (GLOBE NEWSWIRE) -- BliNK Biomedical SAS ("BliNK"), a biopharmaceutical company focused on the discovery and development of novel therapeutic antibodies in oncology and...